Tracking TRALI Risk in Transgender Donors; Assessing 1-Year Deferral Change for MSM Donors

One of the more vexing questions facing blood collection facilities is how to assess anti-HLA antibodies in transgender donors to minimize TRALI risk. Researchers at the American Red Cross (ARC) presented data on the risk of failing to ask transgender (TG) males (birth gender female) about pregnancy. TG males may have had prior pregnancies or … Continue reading “Tracking TRALI Risk in Transgender Donors; Assessing 1-Year Deferral Change for MSM Donors”